$0.032 -0.0 -4.5%
Last Trade - 25/07/18
| Market Cap | ÂŁn/a |
| Enterprise Value | ÂŁn/a |
| Revenue | ÂŁ2.46m |
| Position in Universe | th / 6715 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015E | 2016E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.39 | 0.36 | 0.19 | 0.27 | 1.80 | 2.44 | 4.30 | +44.5% | |||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
OxySure Therapeutics, Inc., formerly OxySure Systems, Inc., offers short duration/emergency duration medical oxygen and respiratory solutions for mass market use. The Company is engaged in the development, distribution and sale of specialty respiratory products and related medical products, accessories and services. The Company's launch product is the OxySure Model 615 portable emergency oxygen system. The Company's products also include Model 615 Replaceable Cartridge; Disposable Resuscitation Bag; OxySure Thermal Bag; OxySure Pulse Oximeter Standard; OxySure Pulse Oximeter Premium; Oxygen 3D Wall Sign; Replacement Mask Adult-Child; Surface Mounted Wall Box; Surface Double Wall Box; OxySure Semi-Recessed, Rolled Edge, Fire Rated Cabinet with Alarm/Strobe; QuikClot Bleeding Control, and OxyTrac Device Tracking System. Its solutions include automated external defibrillators (AEDs) and accessories, resuscitation equipment, and respiratory and monitoring equipment and supplies.
| Last Annual | December 31st, 2014 |
| Last Interim | September 30th, 2015 |
| Incorporated | January 15, 2004 |
| No. of Shareholders: | 76 |
| No. of Employees: | 24 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange | OTC Markets Group |
| Shares in Issue | 36,220,761 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 10880 John W Elliott Dr Ste 600, FRISCO, 75033-3281, United States |
| Web | http://www.oxysure.com/ |
| Phone | +1 972 2946450 |
| Contact | () |
| Auditors | Sadler, Gibb & Associates, LLC |
As of 25/07/18, shares in OxySure Therapeutics Inc are trading at $0.032, giving the company a market capitalisation of ÂŁn/a. This share price information is delayed by 15 minutes.
Shares in OxySure Therapeutics Inc are currently trading at $0.032 and the price has moved by 0.388k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the OxySure Therapeutics Inc price has moved by 0.273k% over the past year.
Of the analysts with advisory recommendations for OxySure Therapeutics Inc, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for OxySure Therapeutics Inc is Not available. You can view the full broker recommendation list by unlocking its StockReport.
OxySure Therapeutics Inc is scheduled to issue upcoming financial results on the following dates:
OxySure Therapeutics Inc does not currently pay a dividend.
OxySure Therapeutics Inc does not currently pay a dividend.
OxySure Therapeutics Inc does not currently pay a dividend.
To buy shares in OxySure Therapeutics Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in OxySure Therapeutics Inc are currently trading at $0.032, giving the company a market capitalisation of ÂŁn/a.
Here are the trading details for OxySure Therapeutics Inc:
We were not able to load our ranking data for OxySure Therapeutics Inc
We were not able to load any forecast data for OxySure Therapeutics Inc.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like OxySure Therapeutics Inc. Over the past six months, the relative strength of its shares against the market has been 0.478k%. At the current price of $0.032, shares in OxySure Therapeutics Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for OxySure Therapeutics Inc.
We were unable to find the directors for OxySure Therapeutics Inc.
Here are the top five shareholders of OxySure Therapeutics Inc based on the size of their shareholding:
